Ireland· IE-PA-EU/1/10/628/003-4

Votrient 400 mg Film-coated tablets

A pazopanib product containing pazopanib hydrochloride, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 2 of our 19 countries.

ATC L01XE11

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pazopanib hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pazopanib is registered in 2 of 19 countries.

Countries holding a registration under ATC L01XE11 (pazopanib), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
1 of them publish a price we can compare per daily dose

Search pazopanib products by name

Pazopanib · ATC L01XE11

2 / 19 countries

Ireland
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)

Active substance: Pazopanib hydrochloride
Manufacturer: Novartis Europharm Limited
Country: Ireland (IE)
ATC code: L01XE11
ATC class: Pazopanib
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1/10/628/003-4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

593 interactions on record for pazopanib.

Graded by severity as the source publishes them — 155 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pazopanib against other medicines How interaction checks work

Pazopanib · interactions on record

593 records

155 severe
428 moderate
10 minor

Most severe, free to view

CimetidineA02BA01severe
RanitidineA02BA02severe
FamotidineA02BA03severe
NizatidineA02BA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pazopanib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pazopanib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Pazopanib Devatis
Belgium · Pazopanib Accord, Pazopanib Eg
Bulgaria · Алуниб, Пазопаниб G.L. Pharma
Cyprus · Pazopanib Sapiens, Pazorem
Czechia · Pazopanib Accord, Pazopanib Sandoz
Germany · Pazopanib Al, Pazopanib Beta
Denmark · Pazopanib Accord, Pazopanib Glenmark
Estonia · Pazopanib Accord, Pazopanib Teva
Spain · Pazopanib Accord, Pazopanib Dr. Reddys
Finland · Pazopanib Accord, Pazopanib Glenmark
France · Pazopanib Accord, Pazopanib Biogaran
United Kingdom (Northern Ireland) · Pazopanib Accord, Pazopanib Accord Healthcare
Greece · Pazopanib Accord, Pazopanib Stada
Croatia · Pazopanib Accord, Pazopanib Frontier
Hungary · Pazopanib Accord, Pazopanib G.L. Pharma
Iceland · Pazopanib Adalvo, Pazopanib Stada
Italy · Pazopanib Accord, Pazopanib Dr. Reddy’s
Liechtenstein · Votrient
Lithuania · Pazopanib Accord, Pazopanib Auxilia
Luxembourg · Pazopanib Eg, Pazopanib Pazopanib Eg
Latvia · Pazopanib Accord, Pazopanib Teva
Malta · Pazopanib Pharmacare, Pazopanib Pharos
Netherlands · Pazopanib Accord, Pazopanib Cf
Norway · Pazopanib Accord, Pazopanib Glenmark
Poland · Pazopanib Accord, Pazopanib Glenmark
Portugal · Pazopanib Accord, Pazopanib Bluepharma
Romania · Pazopanib Accord, Pazopanib Dr. Reddys
Sweden · Pazopanib Accord, Pazopanib Glenmark
Slovenia · Pazopanib Accord, Pazopanib Teva
Slovakia · Pazopanib Accord, Pazopanib G.L. Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/db5d9c5c-c3ef-4878-80e6-0d66ed1234e2
GET /v1/drugs/db5d9c5c-c3ef-4878-80e6-0d66ed1234e2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XE",
    "L01XE11"
  ],
  "strength": null,
  "pa_number": "EU/1/10/628/003-4",
  "substances": [
    "Pazopanib hydrochloride"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "14/06/2010",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0194-068-003"
}

API reference MCP server Plans

See everything about pazopanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console